About Matthew Wyckoff
Matthew Wyckoff is a director at Pierrepont Therapeutics.
Matthew Wyckoff first appears on SEC filings in 2024.
Experience
This experience comes from Matthew Wyckoff's profile and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Wyckoff in the role, so the role may have started earlier or lasted longer.
Pierrepont Therapeutics, Inc. Current
Co-Founder (2023 – Present)
Director
2023 – Present · Brooklyn, NY
Develops treatments for people with primary mitochondrial diseases.
AC
Aceras Current
Founding Partner
2008 – Present
HP
Huxley Pharmaceuticals
Co-Founder and Medical Director
2008 – 2009
Key Colleagues at Startups
The people Matthew Wyckoff works with at each company, as listed on that company's latest Form D.
Pierrepont Therapeutics, Inc. · Form D/A, Sep 22, 2026
PB
Peter Barber
President and director
DD
Daniel DiPietro
Director